The Pharmaceutical Market: United Arab Emirates
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Pharmaceutical</strong> <strong>Market</strong> :<strong>United</strong> <strong>Arab</strong> <strong>Emirates</strong> Trends, Regulations And<br />
Competitive Landscape<br />
"<strong>The</strong> <strong>Pharmaceutical</strong> <strong>Market</strong>: <strong>United</strong> <strong>Arab</strong> <strong>Emirates</strong> "is the latest addition to<br />
<strong>Market</strong>ResearchReports.Biz industry research reports collection.<br />
OVERVIEW OF THE PHARMACEUTICAL MARKET IN UNITED ARAB EMIRATES<br />
<strong>The</strong> <strong>United</strong> <strong>Arab</strong> <strong>Emirates</strong>'healthcare and pharmaceutical markets continue to be<br />
thestrongest in the region.Its growth prospects arestrong we forecast high singledigit<br />
CAGRsover the course of our 10year forecast period. Several factors are driving growth:<br />
incomes are high, as isthe UAE's expatriate population.<strong>The</strong>se elements combine to increase<br />
private healthcare expenditure and demand for innovative drugs.<br />
Local drug production facilities are also gaining strength, with domestic player Julphar<br />
opening a new factory, and multinational drug firms are also entering the market. In<br />
addition, there areplans forseveral new hospital and healthcare facilities,whichwill boost<br />
future demand for pharmaceuticals. <strong>The</strong> UAE's appeal as a medical tourism destination is<br />
another driver of growth.Wethereforeremain optimistic aboutthegrowth potentialof the<br />
<strong>United</strong> <strong>Arab</strong> <strong>Emirates</strong> (UAE)'spharmaceuticalandhealthcaremarkets.<br />
View Report at : http://www.marketresearchreports.biz/analysis/212638<br />
Headline Expenditure Projections<br />
• <strong>Pharmaceutical</strong>s: AED5.56bn (US$1.51bn) in 2011 to AED5.72bn (US$1.56bn) in<br />
2012; +2.9% in local currency and US dollar terms. Forecastunchanged from<br />
Q412.<br />
• Healthcare: AED46.44bn (US$12.64bn) in 2011 to AED52.13bn (US$14.20bn) in<br />
2012; +12.2% in local currency terms and +12.3% in US dollar terms.<br />
Forecastbroadly unchanged from Q412.<br />
• Medical devices: AED1.87bn (US$508mn) in 2011 to AED2.05bn (US$559mn) in<br />
2012; +10.0% in local currency terms and +10.1% in US dollar terms.<br />
Forecastbroadly unchanged from Q412.<br />
Business Environment Rating<br />
In Q1 13, the UAE remains the most attractive market in BMI's Middle East and Africa<br />
(MEA) <strong>Pharmaceutical</strong> Risk/Reward Ratings (RRR) matrix, with its composite score<br />
unchanged at 58.3 out of 100. <strong>The</strong> country has a favourable mediumterm pharmaceutical<br />
market growth forecast.
Competitive Landscape<br />
<strong>The</strong> competitive landscape section provides comparative company analyses and rankings by<br />
US$ sales and % share of total sales for the total pharmaceutical sector, as well as the<br />
OTC, generics, and distribution subsectors.<br />
Download Sample copy of this Report at :<br />
http://www.marketresearchreports.biz/sample/sample/212638<br />
Table of Contents<br />
BMI Industry View7<br />
SWOT9<br />
Business Environment11<br />
Economic12<br />
Political13<br />
Industry Forecast14<br />
<strong>Pharmaceutical</strong> <strong>Market</strong> Forecast14<br />
Table: <strong>Pharmaceutical</strong> Sales Indicators 2009201715<br />
Healthcare <strong>Market</strong> Forecast16<br />
Table: Healthcare Expenditure Indicators 2009201718<br />
Table: Healthcare Governmental Indicators 2009201718<br />
Table: Healthcare Private Indicators 2009201719<br />
Prescription <strong>Market</strong> Forecast19<br />
Table: UAE Healthcare Demand Split By <strong>The</strong>rapeutic Area20<br />
Table: Prescription Drug Sales Indicators 2009201722<br />
Patented Drug <strong>Market</strong> Forecast22<br />
Table: Patented Drug <strong>Market</strong> Indicators, 2009201723<br />
Generic Drug <strong>Market</strong> Forecast23<br />
Table: Generic Drug Sales Indicators, 2009201724<br />
OTC Medicine <strong>Market</strong> Forecast25<br />
Table: OTC Medicine Sales Indicators, 2009201726<br />
<strong>Pharmaceutical</strong> Trade Forecast27<br />
Table: Exports And Imports Indicators, 2009201728<br />
Browse Press Releases by Prweb :
http://www.prweb.com/search.aspx?searchreleases=marketresearchreports.biz<br />
About us<br />
<strong>Market</strong>ResearchReports.biz is the most comprehensive collection of market research<br />
reports. <strong>Market</strong>ResearchReports.Biz services are specially designed to save time and money<br />
for our clients. We are a one stop solution for all your research needs, our main offerings<br />
are syndicated research reports, custom research, subscription access and consulting<br />
services. We serve all sizes and types of companies spanning across various industries.<br />
Contact<br />
Mr. Nachiket<br />
State Tower<br />
90 Sate Street, Suite 700<br />
Albany, NY 12207<br />
Tel: +15186212074<br />
Website: http://www.marketresearchreports.biz/<br />
E: sales@marketresearchreports.biz
Change language